- Home
- MCY vs HCM Comparison
MCY vs HCM Comparison
Compare MCY & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCY
- HCM
- Stock Information
- Founded
- MCY 1961
- HCM 2000
- Country
- MCY United States
- HCM Hong Kong
- Employees
- MCY N/A
- HCM N/A
- Industry
- MCY Property-Casualty Insurers
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- MCY Finance
- HCM Health Care
- Exchange
- MCY Nasdaq
- HCM Nasdaq
- Market Cap
- MCY 3.1B
- HCM 2.5B
- IPO Year
- MCY N/A
- HCM N/A
- Fundamental
- Price
- MCY $53.81
- HCM $13.76
- Analyst Decision
- MCY Strong Buy
- HCM Hold
- Analyst Count
- MCY 1
- HCM 1
- Target Price
- MCY $80.00
- HCM $19.00
- AVG Volume (30 Days)
- MCY 447.6K
- HCM 128.4K
- Earning Date
- MCY 05-06-2025
- HCM 03-19-2025
- Dividend Yield
- MCY 2.36%
- HCM N/A
- EPS Growth
- MCY 385.68
- HCM N/A
- EPS
- MCY 8.45
- HCM 0.04
- Revenue
- MCY $5,475,633,000.00
- HCM $630,201,000.00
- Revenue This Year
- MCY $9.17
- HCM $28.98
- Revenue Next Year
- MCY $7.13
- HCM $20.41
- P/E Ratio
- MCY $6.37
- HCM $63.68
- Revenue Growth
- MCY 18.27
- HCM N/A
- 52 Week Low
- MCY $44.19
- HCM $11.51
- 52 Week High
- MCY $80.72
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- MCY 50.24
- HCM 46.20
- Support Level
- MCY $50.46
- HCM $13.50
- Resistance Level
- MCY $53.97
- HCM $15.11
- Average True Range (ATR)
- MCY 2.24
- HCM 0.66
- MACD
- MCY -0.02
- HCM -0.00
- Stochastic Oscillator
- MCY 67.10
- HCM 45.69
About MCY Mercury General Corporation
Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.